171
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke

, , , , , & show all
Pages 319-324 | Received 06 Dec 2011, Accepted 18 Feb 2012, Published online: 23 Mar 2012

References

  • Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd.. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41.
  • Blum A, Khazim K, Merei M, Peleg A, Blum N, Vaispapir V. (2006). The stroke trial - can we predict clinical outcome of patients with ischemic stroke by measuring soluble cell adhesion molecules (CAM)? Eur Cytokine Netw 17:295–298.
  • Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V. (1989). Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870.
  • Burgess AW, Metcalf D. (1980). Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer 26:647–654.
  • Chambers BR, Norris JW, Shurvell BL, Hachinski VC. (1987). Prognosis of acute stroke. Neurology 37:221–225.
  • del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. (2000). Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95–112.
  • Di Napoli M, Papa F, Bocola V. (2001). Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32:133–138.
  • Di Napoli M, Papa F, Bocola V. (2001). C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32:917–924.
  • Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne MH, Philip PJ. (2007). Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization. J Neurol 254:327–332.
  • England TJ, Abaei M, Auer DP, Lowe J, Jones DR, Sare G, Walker M, Bath PM. (2012). Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 43:405–411.
  • Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502.
  • Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Lennon LT, Thomson AG, Carson C, Ebrahim S, Lowe GD. (2009). Circulating TNFalpha levels in older men and women do not show independent prospective relations with MI or stroke. Atherosclerosis 205:302–308.
  • Jongbloed L. (1986). Prediction of function after stroke: a critical review. Stroke 17:765–776.
  • Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wang X, Haley EC Jr. (2000). A predictive risk model for outcomes of ischemic stroke. Stroke 31:448–455.
  • Kawada H, Takizawa S, Takanashi T, Morita Y, Fujita J, Fukuda K, Takagi S, Okano H, Ando K, Hotta T. (2006). Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113:701–710.
  • Liu CS, Chiang TH, Kuo CL, Ou CC, Lii CK, I SH., Wei YH, Chen HW. (2005). Contribution of plasma folic acid and homocysteine levels to the mean carotid intima media thickness in smokers. Nutr Res 25: 835–845.
  • Paczkowska E, Larysz B, Rzeuski R, Karbicka A, Jalowinski R, Kornacewicz-Jach Z, Ratajczak MZ, Machalinski B. (2005). Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Eur J Haematol 75:461–467.
  • Rader DJ. (2000). Inflammatory markers of coronary risk. N Engl J Med 343:1179–1182.
  • Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW. (2001). Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32:2575–2579.
  • Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR. (2005). The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115:2083–2098.
  • Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, Sommer C, Schwab S. (2003). Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34:745–751.
  • Shyu WC, Lin SZ, Yang HI, Tzeng YS, Pang CY, Yen PS, Li H. (2004). Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110:1847–1854.
  • Shyu WC, Lin SZ, Lee CC, Liu DD, Li H.. (2006). Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 28;174:927–933.
  • Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G. (2006). Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13:505–513.
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587.
  • Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. (2000). Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 31:2597–2602.
  • Tuttolomondo A, Di Raimondo D, Pecoraro R, Serio A, D’Aguanno G, Pinto A, Licata G. (2010a). Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 213:311–318.
  • Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D’Aguanno G, Pinto A, Licata G. (2010b). Arterial stiffness indexes in acute ischemic stroke: relationship with stroke subtype. Atherosclerosis 211:187–194.
  • Vibo R, Kõrv J, Roose M, Kampus P, Muda P, Zilmer K, Zilmer M. (2007). Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free Radic Res 41:282–287.
  • Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. (2002). Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33:2459–2464.
  • Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. (2009). Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 27:247–253.
  • Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, Welsh P, Green A, Andrews M, Sandercock P. (2012). The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 43:86–91.
  • Zhao Y, Luo YM, Xiao BG, Lu CZ. (2006). Fibronectin and neuroprotective effect of granulocyte colony-stimulating factor in focal cerebral ischemia. Brain Res 1098:161–169.
  • Youn CS, Choi SP, Kim SH, Oh SH, Jeong WJ, Kim HJ, Park KN. (2012). Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med 30:124–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.